Clinical trial
Rosiglitazone-Induced Weight Gain
NCT00225225 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rosiglitazone-Induced Weight Gain
- Lead sponsor
- Stanford University
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- October 31, 2002
- Completion date
- September 30, 2005
- Enrollment
- 45 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.